NASDAQ:BJDX

Bluejay Diagnostics Stock Forecast, Price & News

$3.12

-0.22 (-6.59%)

(As of 11/30/2021 10:02 AM ET)

Add

Compare

Today's Range: $3.12
▼
$3.38
50-Day Range: N/A
52-Week Range: $2.65
▼
$6.25

Volume: 261 shs
Average Volume: 1.85 million shs
Market Capitalization: $39.59 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive BJDX News and Ratings via Email

Sign-up to receive the latest news and ratings for Bluejay Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

About Bluejay Diagnostics

Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass.

Bluejay Diagnostics Inc.
November 17, 2021 | wsj.com

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering
November 15, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: N/A
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:BJDX
Previous Symbol
CUSIP: N/A
CIK: 1704287
Web: N/A
Phone: N/A
Fax: N/A
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 12,690,000
Free Float: N/A
Market Cap: $39.59 million
Optionable: Not Optionable

Company Calendar

Today: 11/30/2021
Fiscal Year End: 12/31/2021

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

1390th out of 1,390 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Bluejay Diagnostics.

0.0 Community Rank

Outperform Votes
Bluejay Diagnostics has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Bluejay Diagnostics has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Bluejay Diagnostics and other stocks. Vote “Outperform” if you believe BJDX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BJDX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Bluejay Diagnostics does not currently pay a dividend.
Dividend Growth
Bluejay Diagnostics does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Bluejay Diagnostics insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Bluejay Diagnostics (NASDAQ:BJDX) Frequently Asked Questions

Who are some of Bluejay Diagnostics' key competitors?: Some companies that are related to Bluejay Diagnostics include Repro Med Systems (KRMD), Aptinyx (APTX), Milestone Scientific (MLSS), Larimar Therapeutics (LRMR), Elevation Oncology (ELEV), Kaleido Biosciences (KLDO), Anebulo Pharmaceuticals (ANEB), ImmunoPrecise Antibodies (IPA), BriaCell Therapeutics (BCTX), Satsuma Pharmaceuticals (STSA), ARYA Sciences Acquisition Corp IV (ARYD), Actinium Pharmaceuticals (ATNM), AIT Therapeutics (AITB), Genfit (GNFT) and Equillium (EQ).
View all of BJDX's competitors.
When did Bluejay Diagnostics IPO?: (BJDX) raised $22 million in an initial public offering on Wednesday, November 10th 2021. The company issued 2,160,000 shares at $10.00 per share.
What is Bluejay Diagnostics' stock symbol?: Bluejay Diagnostics trades on the NASDAQ under the ticker symbol "BJDX."
When does Bluejay Diagnostics' quiet period expire?: Bluejay Diagnostics' quiet period expires on Monday, December 20th. Bluejay Diagnostics had issued 2,160,000 shares in its public offering on November 10th. The total size of the offering was $21,600,000 based on an initial share price of $10.00. During Bluejay Diagnostics' quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
How do I buy shares of Bluejay Diagnostics?: Shares of BJDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Bluejay Diagnostics' stock price today?: One share of BJDX stock can currently be purchased for approximately $3.12.
How much money does Bluejay Diagnostics make?: Bluejay Diagnostics has a market capitalization of $39.59 million.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.